A detailed history of Aberdeen Wealth Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Aberdeen Wealth Management LLC holds 14,540 shares of NVS stock, worth $1.6 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
14,540
Previous 13,740 5.82%
Holding current value
$1.6 Million
Previous $1.39 Million 1.37%
% of portfolio
0.85%
Previous 1.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $76,216 - $86,776
800 Added 5.82%
14,540 $1.41 Million
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $73,816 - $81,232
-800 Reduced 5.5%
13,740 $1.39 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $9,473 - $10,513
-100 Reduced 0.68%
14,540 $1.48 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $149 - $174
-2 Reduced 0.01%
14,640 $1.11 Million
Q2 2022

Aug 10, 2022

SELL
$80.52 - $93.75 $5,716 - $6,656
-71 Reduced 0.48%
14,642 $1.24 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $7,491 - $8,284
-94 Reduced 0.63%
14,713 $1.29 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $38,109 - $44,335
-466 Reduced 3.05%
14,807 $1.21 Million
Q2 2021

Jul 23, 2021

BUY
$85.24 - $94.15 $7,245 - $8,002
85 Added 0.56%
15,273 $1.39 Million
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $6,262 - $7,385
-75 Reduced 0.49%
15,188 $1.3 Million
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $33,513 - $37,128
-408 Reduced 2.6%
15,263 $1.33 Million
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $29,539 - $33,251
365 Added 2.38%
15,671 $1.37 Million
Q1 2020

May 08, 2020

SELL
$70.67 - $99.01 $12,367 - $17,326
-175 Reduced 1.13%
15,306 $1.26 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $1.31 Million - $1.48 Million
15,481 New
15,481 $1.47 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $236B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Aberdeen Wealth Management LLC Portfolio

Follow Aberdeen Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aberdeen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aberdeen Wealth Management LLC with notifications on news.